Product Details:
| Strength | 100 mg |
| Packaging Type | Box |
| Packaging Size | 1 ml |
| Brand | CYTARAMAX 100 |
| Manufacturer | GLS Pharma Pvt. Ltd. |
| Country of Origin | Made in India |
Cytaramax 100 Injection 1 ml is an anticancer medicine used in the treatment of leukemia. Leukemia, also known as blood cancer, is a cancer of blood cells or blood-forming tissues. It causes excessive production of immature white blood cells by the bone marrow and reduces the body’s ability to fight infections. Cytaramax 100 Injection 1 ml is used in the treatment of different types of leukemias, such as acute non-lymphocytic leukemia, acute lymphocytic leukemia, chronic myelocytic leukemia and meningeal leukemia. Cytaramax 100 Injection 1 ml contains Cytarabine, which belongs to the class of antimetabolites. It works by inhibiting the DNA polymerase enzyme responsible for DNA elongation, synthesis, and repair. In general, it inhibits the production of genetic material (DNA) in the cancer cells that are essential for the growth, repair and multiplication of cells. Thus, Cytaramax 100 Injection 1 ml stops the multiplication of abnormal cells, leads to the growth of cells in an unbalanced way and causes the death of cells.